Manuel Garcia-Toca, MD
General Surgery · Atlanta
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 3 carriers
- Office
- 1
Offices
1 location · Emory Medical Care Foundation Inc · 1,003 clinicians in this group
Hospitals listed: Grady Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
10 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Garcia-Toca’s office at (404) 616-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C133988 · Current
Licensed to practise in California · since 2014 · expires 2026-11-30 · University of Anahuac School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Grady Memorial HospitalAtlanta, GAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Grady Health SystemPatients rate it 2 of 5 · 69% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.349, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.293, Oct 2024 – Sep 2025
See every measure and the patient survey for Grady Memorial Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 3 better, 3 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.349 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.293 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.15 (0.14 to 2.16) · 670 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.23 (0.89 to 1.57) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.15 (122.51 to 207.79) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 916 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,156 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.37 (0.17 to 0.58) · 5,874 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,441 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.03 (2.96 to 7.1) · 949 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.79 (0.27 to 3.3) · 1,062 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.37 (6.68 to 24.06) · 159 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.47 (0.46 to 8.48) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.17 to 1.25) · 5,344 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 47 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.329 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.302 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.807 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.699 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.1 · 85 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.3 · 750 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 63.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.6 · 127 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 7.9) · 70 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (6.6 to 13.9) · 70 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 301 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.1) · 95 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 32 cases | No different | Jan 2024 – Dec 2024 |
What patients said (726 patients answered, 8% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 79% |
Original Medicare doctor bills
$35,665
Medicare paid this office $35,665 for 171 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $3,485 | $100 |
| Return visit (30+ min) | 24 | $1,904 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,632 | $136 |
| Short return visit (20+ min) | 21 | $1,294 | $52 |
| Complete ultrasound study of arm and leg arteries | 29 | $457 | $16 |
See all 7 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $3,485 | $100 |
| Return visit (30+ min) | 24 | $1,904 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,632 | $136 |
| Short return visit (20+ min) | 21 | $1,294 | $52 |
| Complete ultrasound study of arm and leg arteries | 29 | $457 | $16 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 19 | $385 | $20 |
| Ultrasound study of arm and leg arteries | 13 | $121 | $9 |
Procedures Medicare counted
| Removal of tissue | 15 | More than 66% of doctors who do this |
Who their Medicare patients are
171 Original Medicare patients in 2024. Average age 71 · Under 65 16% · 85 and older 10% · Women 47% · Also on Medicaid 60% · Health risk score 2.99. Sicker patients than 9 in 10 peers; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 75% · Diabetes 63% · Chronic kidney disease 56% · Heart failure 47% · Coronary heart disease 44% · Stroke 31% · Atrial fibrillation 30% · COPD 26% · Depression 25% · Dementia 21% · Cancer 11%.
The office billed $206,964, Medicare allowed $45,528 and paid $35,665; for 323 services of 66 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 171 | 323 | 71 | 2.99 | $206,964 | $35,665 |
| 2023 | 142 | 231 | 68 | 3.78 | $135,704 | $25,062 |
| 2022 | 226 | 500 | 69 | 3.82 | $703,001 | $67,126 |
| 2021 | 213 | 415 | 70 | 4.52 | $458,348 | $47,470 |
| 2020 | 170 | 338 | 69 | 4.42 | $485,322 | $47,985 |
| 2019 | 210 | 357 | 69 | 4.40 | $388,657 | $42,786 |
| 2018 | 226 | 425 | 68 | 4.07 | $412,794 | $55,509 |
| 2017 | 217 | 386 | 67 | 4.29 | $371,371 | $50,547 |
| 2016 | 217 | 385 | 67 | 4.22 | $460,904 | $52,890 |
| 2015 | 156 | 285 | 67 | 4.22 | $396,653 | $42,550 |
| 2014 | 233 | 1,250 | 73 | 2.12 | $491,269 | $102,777 |
| 2013 | 233 | 778 | 72 | 2.16 | $485,892 | $109,568 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,755 | $104 |
| Complete ultrasound study of arm and leg arteries | 36 | $662 | $17 |
| Short return visit (20+ min) | 11 | $583 | $53 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 20 | $533 | $25 |
2022: 5 services
| Short return visit (20+ min) | 161 | $15,096 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $3,187 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,555 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,447 | $74 |
| Short return visit | 34 | $1,539 | $33 |
2021: 5 services
| Short return visit (20+ min) | 125 | $10,609 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,839 | $114 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,505 | $147 |
| Short return visit | 53 | $2,193 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,858 | $74 |
2020: 6 services
| Relocation of arm vein with connection to arm artery for hemodialysis | 15 | $8,612 | $574 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $4,601 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,826 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $3,554 | $148 |
| Short return visit (20+ min) | 63 | $3,265 | $46 |
| Short return visit | 31 | $881 | $22 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,504 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,230 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,651 | $66 |
| Short return visit | 92 | $2,437 | $21 |
| Short return visit (20+ min) | 31 | $1,492 | $45 |
| New patient visit (10+ min) | 21 | $439 | $21 |
2018: 7 services
| Relocation of arm vein with connection to arm artery for hemodialysis | 11 | $6,281 | $571 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,837 | $65 |
| Short return visit | 124 | $3,285 | $21 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,444 | $122 |
| New patient visit (45+ min) | 23 | $2,306 | $100 |
| Short return visit (20+ min) | 32 | $1,336 | $40 |
| New patient visit (30+ min) | 20 | $1,004 | $50 |
2017: 6 services
| Relocation of arm vein with connection to arm artery for hemodialysis | 23 | $13,151 | $572 |
| Short return visit (20+ min) | 84 | $3,781 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,850 | $65 |
| Short return visit | 77 | $2,114 | $21 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,435 | $90 |
| Return visit (30+ min) | 17 | $917 | $54 |
2016: 5 services
| Relocation of arm vein with connection to arm artery for hemodialysis | 16 | $9,834 | $578 |
| Short return visit (20+ min) | 105 | $5,051 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,696 | $64 |
| Short return visit | 69 | $1,748 | $21 |
| Return visit (30+ min) | 25 | $1,611 | $64 |
2015: 6 services
| Relocation of arm vein with connection to arm artery for hemodialysis | 11 | $4,902 | $446 |
| Short return visit (20+ min) | 56 | $2,526 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,156 | $64 |
| Return visit (30+ min) | 15 | $1,035 | $69 |
| Short return visit (20+ min) | 21 | $844 | $40 |
| Short return visit | 32 | $720 | $22 |
2014: 10 services
| Short return visit (20+ min) | 179 | $15,647 | $56 |
| Ultrasound of both sides of head and neck blood flow | 39 | $6,033 | $137 |
| Complete ultrasound study of arm and leg arteries | 40 | $4,228 | $103 |
| New patient visit (30+ min) | 38 | $3,245 | $85 |
| Ultrasound of leg arteries or artery grafts | 13 | $2,885 | $170 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 18 | $2,791 | $155 |
| Ultrasound study of arm and leg arteries | 34 | $2,687 | $56 |
| Ultrasound of one leg arteries or artery grafts | 17 | $2,640 | $110 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $2,462 | $176 |
| Short return visit | 22 | $1,968 | $34 |
2013: 10 services
| Short return visit (20+ min) | 136 | $10,359 | $56 |
| Ultrasound of both sides of head and neck blood flow | 28 | $5,186 | $140 |
| Complete ultrasound study of arm and leg arteries | 41 | $4,935 | $112 |
| Short return visit | 87 | $4,393 | $30 |
| New patient visit (30+ min) | 47 | $4,049 | $86 |
| Ultrasound of leg arteries or artery grafts | 17 | $2,933 | $147 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 18 | $2,858 | $143 |
| Ultrasound study of arm and leg arteries | 27 | $2,024 | $60 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $1,846 | $154 |
| Ultrasound of one leg arteries or artery grafts | 15 | $1,564 | $98 |
Medicaid work
$1,079 in 2024
Medicaid paid $1,079 for 74 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure measurements with bidirectional Doppler waveform recording and analysis, at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental volume plethysmography at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental transcutaneous oxygen tension measurements at 3 or more levels), or single level study with provocative functional maneuvers (eg, measurements with postural provocative tests, or measurements with reactive hyperemia) | 50 | $638 |
| Short return visit (20+ min) | 12 | $339 |
| Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels) | 12 | $102 |
| 2024 | 74 | 3 | 15 | $1,079 |
| 2023 | 66 | 1 | 22 | $582 |
| 2022 | 723 | 4 | 79 | $5,999 |
| 2021 | 573 | 2 | 56 | $3,451 |
| 2020 | 221 | 2 | 36 | $1,488 |
| 2019 | 234 | 2 | 32 | $939 |
| 2018 | 241 | 2 | 41 | $761 |
See the largest Medicaid services in earlier years
2023
| Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure measurements with bidirectional Doppler waveform recording and analysis, at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental volume plethysmography at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental transcutaneous oxygen tension measurements at 3 or more levels), or single level study with provocative functional maneuvers (eg, measurements with postural provocative tests, or measurements with reactive hyperemia) | 66 | $582 |
2022
| Short return visit (20+ min) | 604 | $4,476 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $1,059 |
| Short return visit | 82 | $271 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $194 |
2021
| Short return visit (20+ min) | 447 | $3,060 |
| Short return visit | 126 | $391 |
2020
| Short return visit (20+ min) | 106 | $909 |
| Short return visit | 115 | $579 |
2019
| Short return visit | 222 | $918 |
| Short return visit (20+ min) | 12 | $21 |
2018
| Short return visit | 229 | $691 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $70 |
Drugs they prescribed that Part D paid
$12,894
Pharmacies billed $12,894 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
67 generic and 17 brand-name prescriptions · $12,894 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 12 | $46 | $4 |
Year by year
| 2024 | 84 | 34 | None | 20% | $12,894 |
| 2023 | 52 | 18 | None | None | $6,518 |
| 2022 | 57 | 30 | 0% (0) | 23% | $12,828 |
| 2021 | 76 | 32 | None | None | $4,885 |
| 2020 | 13 | None | None | None | $316 |
| 2019 | 20 | None | 0% (0) | 0% | $453 |
| 2018 | 24 | 12 | 0% (0) | None | $267 |
| 2017 | 71 | 32 | 21% (15) | 0% | $739 |
| 2016 | 82 | 29 | None | 0% | $1,011 |
| 2015 | 142 | 40 | None | None | $1,572 |
| 2014 | 272 | 59 | 7% (19) | None | $5,509 |
| 2013 | 221 | 60 | 13% (28) | None | $4,967 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 2 drugs
| Pentoxifylline | 17 | $744 | $44 |
| Cilostazol | 20 | $316 | $16 |
2017: 3 drugs
| Cilostazol | 26 | $355 | $14 |
| Clopidogrel | 13 | $102 | $8 |
| Hydrocodone-Acetaminophen | 12 | $72 | $6 |
2016: 1 drug
| Cilostazol | 48 | $624 | $13 |
2015: 4 drugs
| Cilostazol | 62 | $628 | $10 |
| Clopidogrel | 37 | $538 | $15 |
| Gabapentin | 17 | $223 | $13 |
| Simvastatin | 14 | $69 | $5 |
2014: 3 drugs
| Cilostazol | 100 | $2,289 | $23 |
| Gabapentin | 37 | $828 | $22 |
| Clopidogrel | 52 | $645 | $12 |
2013: 5 drugs
| Cilostazol | 62 | $1,740 | $28 |
| Clopidogrel | 66 | $1,637 | $25 |
| Gabapentin | 11 | $143 | $13 |
| Cephalexin | 13 | $141 | $11 |
| Hydrocodone-Acetaminophen | 22 | $106 | $5 |
Money from drug and device companies
$2,179 in 2025
| 2025 | 9 | 27 | None | $2,179 |
| 2024 | 5 | 7 | None | $613 |
| 2023 | 4 | 5 | None | $754 |
| 2022 | 7 | 13 | None | $1,109 |
| 2021 | 9 | 13 | None | $1,137 |
| 2019 | 6 | 9 | None | $422 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| W. L. Gore & Associates | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $1,214 | 13 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $327 | 3 payments
|
| Cook Medical | Zenith Alpha | $185 | 2 payments
|
| Humacyte Global | None | $144 | 2 payments
|
| Bolton Medical | Relay Thoracic Stent-Graft With Plus Delivery System | $137 | 1 payment
|
| ETS Wound Care | Mirragen Advanced Wound Matrix | $77 | 3 payments
|
See all 27 published payments
| Shockwave Medical | Meals · 2025-11-21 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $100 |
| Shockwave Medical | Meals · 2025-11-21 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $39 |
| Humacyte Global | Meals · 2025-11-20 | None | $67 |
| ETS Wound Care | Meals · 2025-11-07 | Mirragen Advanced Wound Matrix | $7 |
| Cook Medical | Meals · 2025-10-10 | Zenith Spiral-Z | $86 |
| Humacyte Global | Meals · 2025-10-09 | None | $77 |
| ETS Wound Care | Meals · 2025-10-07 | Mirragen Advanced Wound Matrix | $27 |
| CashFlow Solutions | Meals · 2025-09-25 | Lympha Press Optimal Plus(US) Bt | $15 |
| Smith+Nephew | Meals · 2025-08-20 | Pico 14 | $18 |
| ETS Wound Care | Meals · 2025-07-08 | Mirragen Advanced Wound Matrix | $43 |
| Bolton Medical | Meals · 2025-07-01 | Relay Thoracic Stent-Graft With Plus Delivery System | $137 |
| W. L. Gore & Associates | Meals · 2025-06-02 | Gore Viabahn Vbx Balloon Expandable Endo | $94 |
| Shockwave Medical | Meals · 2025-05-22 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $188 |
| W. L. Gore & Associates | Travel · 2025-04-10 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $20 |
| W. L. Gore & Associates | Travel · 2025-04-07 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $109 |
| Cook Medical | Meals · 2025-03-31 | Zenith Alpha | $99 |
| W. L. Gore & Associates | Travel · 2025-03-30 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $193 |
| W. L. Gore & Associates | Meals · 2025-03-30 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $162 |
| W. L. Gore & Associates | Meals · 2025-03-26 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $145 |
| W. L. Gore & Associates | Meals · 2025-03-24 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $25 |
| W. L. Gore & Associates | Meals · 2025-03-24 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $33 |
| W. L. Gore & Associates | Meals · 2025-03-24 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $4 |
| W. L. Gore & Associates | Meals · 2025-03-24 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $40 |
| W. L. Gore & Associates | Meals · 2025-03-24 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $4 |
| W. L. Gore & Associates | Travel · 2025-02-25 | Gore Excluder Thoracoabdominal Branch Endoprosthesis | $213 |
| AtriCure | Meals · 2025-02-20 | Atricure Cryoice Cryosphere Cryoablation System | $61 |
| W. L. Gore & Associates | Meals · 2025-02-04 | Gore Viabahn Vbx Balloon Expandable Endo | $172 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $613
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $391 | 2 payments
|
| W. L. Gore & Associates | Gore Excluder Aaa Endoprosthesis | $92 | 1 payment
|
| Boston Scientific | Eluvia | $72 | 1 payment
|
| Medtronic | Endurant Iis | $29 | 1 payment
|
| Smith+Nephew | Grafix | $28 | 2 payments
|
2023: $754
| Medtronic | Endurant Iis | $221 | 2 payments
|
| Abbott Laboratories | Jeti | $182 | 1 payment
|
| Inari Medical | Flowtriever Catheter, S | $182 | 1 payment
|
| W. L. Gore & Associates | Gore Viabahn Endoprosthesis | $168 | 1 payment
|
2022: $1,109
| Bolton Medical | Grafts | $429 | 4 payments
|
| Inari Medical | Flowtriever Catheter, S | $289 | 2 payments
|
| W. L. Gore & Associates | Gore Tag Conformable Thoracic Endoprosthesis | $152 | 2 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $126 | 2 payments
|
| Medtronic | Endurant Iis | $60 | 1 payment
|
| Cook Medical | Cook | $27 | 1 payment
|
| Bard Peripheral Vascular | None | $25 | 1 payment
|
2021: $1,137
| Bolton Medical | Relay Grafts | $260 | 2 payments
|
| W. L. Gore & Associates | C3 Delivery System | $187 | 1 payment
|
| Viz.ai | Viz.Ai Lvo | $183 | 1 payment
|
| Penumbra | Indigo System | $169 | 2 payments
|
| Silk Road Medical | Enhance Transcarotid Peripheral Access Kit | $126 | 1 payment
|
| Philips Electronics North America | (6554) Periph Vasc Undiv | $106 | 2 payments
|
| Becton Dickinson and | Wavelinq | $51 | 2 payments
|
| Inari Medical | Flowtriever Catheter, S | $38 | 1 payment
|
| Bard Peripheral Vascular | None | $19 | 1 payment
|
2019: $422
| W. L. Gore & Associates | Excluder Iliac Branch Endoprosthesis | $141 | 2 payments
|
| Bolton Medical | Relay Plus | $117 | 1 payment
|
| Penumbra | Indigo | $79 | 1 payment
|
| Medtronic Vascular | Endurant | $44 | 3 payments
|
| Cook Medical | None | $24 | 1 payment
|
| Bard Peripheral Vascular | Wavelinq | $16 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Nct06656364--Esprit Btk Post-Approval Study · 2025 | Their institution | $40,232 |
| Boston Scientific Corporation · Elegance · 2025 | Their institution | $23,645 |
| Humacyte Global, Inc. · To Compare the Efficacy and Safety of the Atev With Avf in Female Patients With End-Stage Renal Disease Requiring Hemodialysis · 2025 | Their institution | $7,510 |
| Abbott Laboratories · Esprit Btk Post-Approval Study (Espritbtkpas) · 2024 | Their institution | $5,940 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1437377280
- Licence
- CA 133988, RI MD13238California C133988: Current · expires 2026-11-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2086S0129X (2086S0129X)
- Mailing address
- 1804 Embarcadero Rd, Suite 100, Palo Alto, CA, 94303
- NPI first listed
- 2007-04-24
- NPI last updated
- 2015-12-02
This is when the NPI record was last certified, not a medical board exam.